Paul Burton
CIK 1869869 · View on SEC EDGAR ↗
First SEC filing: Nov. 8, 2022 · Latest: Nov. 8, 2022
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 7, 2022 | MRNA | S | 192 | $158.68 | $30,467 | 954 Direct | -16.75% | Disposed | -9.7% (price as of 2026-08-20) |
| Aug. 8, 2022 | MRNA | S | 865 | $185.10 | $160,112 | 744 Direct | -53.76% | Disposed | -22.6% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 4, 2022 | MRNA | Restricted Stock Units | Common Stock (402) | $0.00 | — | 402 | Disposed |
| Aug. 5, 2022 | MRNA | Restricted Stock Units | Common Stock (1,609) | $0.00 | — | 1,609 | Disposed |
| June 16, 2022 | MRNA | Restricted Stock Units | Common Stock (10,990) | $0.00 | — | 10,990 | Acquired |
| June 16, 2022 | MRNA | Stock Option (Right to Buy) | Common Stock (19,772) | $121.08 | June 16, 2032 | 19,772 | Acquired |
| June 16, 2022 | MRNA | Restricted Stock Units | Common Stock (3,663) | $0.00 | — | 3,663 | Acquired |
| June 16, 2022 | MRNA | Stock Option (Right to Buy) | Common Stock (6,902) | $121.08 | June 16, 2032 | 6,902 | Acquired |
| March 1, 2022 | MRNA | Restricted Stock Units | Common Stock (1,603) | $0.00 | — | 1,603 | Acquired |
| March 1, 2022 | MRNA | Stock Option (Right to Buy) | Common Stock (6,505) | $149.52 | March 1, 2032 | 6,505 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).